This document describes how a pharmaceutical company maximizes efficiency in early drug discovery by using Agilent Analytical Studio Reviewer (ASR) for high-throughput LC/MS analyses to determine the correct compounds. The company is one of the largest pharmaceutical companies in Japan, with a focus on developing drugs in the therapeutic categories of urology, immunology and infectious diseases, oncology, neuroscience, diabetes mellitus complications, and metabolic diseases.
This document presents a customer success story involving a major Japanese pharmaceutical company with 200 medicinal chemists. The department utilizes high-throughput LC/MS analyses to determine the correctness of synthesized compounds, relying on Agilent 6100 Series Single Quadrupole LC/MS Systems and Easy Access software.
Agilent Analytical Studio Reviewer (ASR) was adopted to further increase productivity by enabling efficient, customizable data review and reporting. The software allows scientists to view chromatograms and spectra from multiple detectors, generate user-configurable PDF reports, and upload results to data management systems like OpenLAB Electronic Content Manager.
It enables efficient, customizable data review and reporting for high-throughput LC/MS analyses of synthesis products.
The company acquired 200 licenses for use by their chemists.
The equipment configuration typically provides analyses with run times of three minutes.